{
  "ptid_time": "014_S_4058_2011-05-26",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4058/2011-05-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 27,036 mm³, 26.9% below the reference mean. With a Z-score of -0.73 (23.4th percentile), this represents normal volume ; hippocampal volume measures 6,259 mm³, 3.6% below the reference mean. With a Z-score of -0.29 (38.5th percentile), this represents normal volume ; whole brain volume measures 921,513 mm³, 0.7% below the reference mean. With a Z-score of -0.09 (46.6th percentile), this represents normal volume ; entorhinal cortex volume measures 2,570 mm³, 25.8% below the reference mean. With a Z-score of -1.39 (8.2th percentile), this represents mild atrophy; fusiform gyrus volume measures 15,340 mm³, 4.8% below the reference mean. With a Z-score of -0.36 (36.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,598 mm³, 13.5% below the reference mean. With a Z-score of -1.20 (11.5th percentile), this represents mild atrophy. ",
  "text_data": "Age is 84.6 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Alcohol Abuse; Major Surgical Procedures. MMSE: 29.0. MoCA: 20.0. Logical Memory: 0.0. Laboratory findings: AST (SGOT): 40.00 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated); Amyloid beta: 434.50 pg/mL (moderate reduced); Total tau: 283.70 pg/mL (normal ); Phosphorylated tau: 28.03 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild atrophy in the entorhinal cortex and middle temporal gyrus, which are early Alzheimer's-related regions, alongside moderately reduced Aβ and significantly elevated AV45 (amyloid PET), suggesting amyloid pathology. However, hippocampal and whole-brain volumes are normal, and MMSE is high (29/30), though MoCA (20/30) indicates mild cognitive impairment.  \n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (Strong amyloid evidence but conflicting cognitive scores—MMSE near-normal vs. MoCA impairment—and no significant hippocampal atrophy typically seen in dementia.)  \n\n*(Key considerations: Elevated amyloid + entorhinal/middle temporal atrophy aligns with early AD progression, but preserved hippocampal volume and high MMSE suggest MCI rather than dementia. APOE4 carrier status and age increase AD risk.)*",
  "timestamp": "2025-07-25T23:50:14.846012"
}